New cases of mpox diagnosed in Montreal: public health
One month almost to the day after the health ministry officially announced the end of the mpox outbreak in Quebec, new cases have appeared in Montreal, according to public health.
In an update of its "call for vigilance," the Montreal public health agency said that "after several months without reporting new cases" in the city, two laboratory-confirmed cases have been reported since March 17.
This infectious disease, previously known as monkeypox, disproportionately affects men who have sex with men. The two recently reported cases are believed to be linked to men who have travelled to countries where local transmission is well documented.
While the epidemic was considered over in Montreal and Quebec, the World Health Organization (WHO) said it is still a "public health emergency of international concern."
According to information provided by Montreal Public Health, the two recently infected individuals both received at least one dose of the preventive vaccine Imvamune, which reduces the risk of contracting the disease and developing serious complications.
The virus is transmitted through direct skin or mucous membrane contact with an infected person's lesions or biological fluids. It can also be transmitted by respiratory droplets during prolonged close contact.
The main symptoms are fever, headache, fatigue, chills, body aches and swollen lymph nodes. Rashes then appear on the face and elsewhere on the body. These rashes can be very painful, health experts warn.
MORE THAN 500 CASES
Between May and October 2022, about 400 probable and confirmed cases of mpox were diagnosed in Montreal. Across Quebec, the Ministry of Health counted 526 probable or confirmed cases in connection with this outbreak.
A rapid vaccination campaign deployed by Montreal Public Health in the summer of 2022 slowed the spread of mpox.
It is estimated that 54 per cent of the population at risk in the Montreal area received a first dose of the vaccine, while 24 per cent received a second dose.
Public health is calling for vigilance among health professionals to identify other cases and promote the preventive vaccine to people who are at risk.
This report by The Canadian Press was first published in French on March 30, 2023. The Canadian Press health content receives funding through a partnership with the Canadian Medical Association. The Canadian Press is solely responsible for editorial decisions.
CTVNews.ca Top Stories
'A beautiful soul': Funeral held for baby boy killed in wrong-way crash on Highway 401
A funeral was held on Wednesday for a three-month-old boy who died after being involved in a wrong-way crash on Highway 401 in Whitby last week.
'Sophisticated' cyberattacks detected on B.C. government networks, premier says
There has been a "sophisticated" cybersecurity breach detected on B.C. government networks, Premier David Eby confirmed Wednesday evening.
Police handcuff man trying to enter Drake's Toronto mansion
Toronto police say a man was taken into custody outside Drake's Bridle Path mansion Wednesday afternoon after he tried to gain access to the residence.
Biden says he will stop sending bombs and artillery shells to Israel if they launch major invasion of Rafah
U.S. President Joe Biden said for the first time Wednesday he would halt shipments of American weapons to Israel, which he acknowledged have been used to kill civilians in Gaza, if Prime Minister Benjamin Netanyahu orders a major invasion of the city of Rafah.
Rookie goalie Arturs Silovs to start for Canucks in Game 1 vs. Oilers
Rookie goalie Arturs Silovs will start in net for the Canucks as Vancouver kicks off a second-round series against the Edmonton Oilers Wednesday night.
Nijjar murder suspect says he had Canadian study permit in immigration firm's video
One of the Indian nationals accused of murdering British Columbia Sikh activist Hardeep Singh Nijjar says in a social media video that he received a Canadian study permit with the help of an Indian immigration consultancy.
Pfizer agrees to settle more than 10K lawsuits over Zantac cancer risk: Bloomberg News
Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.
Quebec premier defends new museum on Quebecois nation after Indigenous criticism
Quebec Premier Francois Legault is defending his comments about a new history museum after he was accused by a prominent First Nations group of trying to erase their history.
U.S. presidential candidate RFK Jr. had a brain worm, has recovered, campaign says
Independent U.S. presidential candidate Robert F. Kennedy Jr. had a parasite in his brain more than a decade ago, but has fully recovered, his campaign said, after the New York Times reported about the ailment.